Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Autoimmunity
|
July 3, 2016
Immunomodulators in SLE: Clinical evidence and immunologic actions
L Durcan, M Petri
Lupus
|
August 7, 2016
Why targeted therapies are necessary for systemic lupus erythematosus
L Durcan, M Petri
Seminars in Arthritis and Rheumatism
|
September 11, 2020
The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort
L Durcan, M Petri
Irish Medical Journal
|
March 9, 2012
Fracture liaison service in a non-regional orthopaedic clinic--a cost-effective service
M Ahmed, L Durcan, J O'Beirne, et al.
Lupus
|
April 11, 2017
Ribosomal P antibody: 30 years on the road
V T Viana, L Durcan, E Bonfa, et al.
Journal of the Neurological Sciences
|
October 1, 1996
Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics
J D Stewart, R McKelvey, L Durcan, et al.
QJM : Monthly Journal of the Association of Physicians
|
July 23, 2020
Isolated interstitial lung disease associated with anti-Ku autoantibodies: a case responding to a CD20 inhibitor
C Ottewill, S Aamir, D Nash, et al.
Journal of Science and Medicine in Sport
|
July 11, 2013
The prevalence of patellar tendinopathy in elite academy rugby: a clinical and imaging study
L Durcan, A Coole, E McCarthy, et al.
British Journal of Cancer
|
February 13, 2015
An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis
T Maishman, E Copson, L Stanton, et al.
British Journal of Cancer
|
October 24, 2013
Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study
E Copson, T Maishman, S Gerty, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Autoimmunity
|
July 3, 2016
Immunomodulators in SLE: Clinical evidence and immunologic actions
L Durcan, M Petri
Lupus
|
August 7, 2016
Why targeted therapies are necessary for systemic lupus erythematosus
L Durcan, M Petri
Seminars in Arthritis and Rheumatism
|
September 11, 2020
The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort
L Durcan, M Petri
Irish Medical Journal
|
March 9, 2012
Fracture liaison service in a non-regional orthopaedic clinic--a cost-effective service
M Ahmed, L Durcan, J O'Beirne, et al.
Lupus
|
April 11, 2017
Ribosomal P antibody: 30 years on the road
V T Viana, L Durcan, E Bonfa, et al.
Journal of the Neurological Sciences
|
October 1, 1996
Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics
J D Stewart, R McKelvey, L Durcan, et al.
QJM : Monthly Journal of the Association of Physicians
|
July 23, 2020
Isolated interstitial lung disease associated with anti-Ku autoantibodies: a case responding to a CD20 inhibitor
C Ottewill, S Aamir, D Nash, et al.
Journal of Science and Medicine in Sport
|
July 11, 2013
The prevalence of patellar tendinopathy in elite academy rugby: a clinical and imaging study
L Durcan, A Coole, E McCarthy, et al.
British Journal of Cancer
|
February 13, 2015
An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis
T Maishman, E Copson, L Stanton, et al.
British Journal of Cancer
|
October 24, 2013
Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study
E Copson, T Maishman, S Gerty, et al.
Page
of 2